Compare DPRO & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DPRO | LFMD |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.8M | 218.1M |
| IPO Year | 2019 | 2012 |
| Metric | DPRO | LFMD |
|---|---|---|
| Price | $5.95 | $2.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $15.00 | $9.14 |
| AVG Volume (30 Days) | ★ 1.8M | 806.9K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 141.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,468,578.00 |
| Revenue This Year | $158.69 | $17.52 |
| Revenue Next Year | $131.85 | $18.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $3.78 | $2.60 |
| 52 Week High | $14.37 | $7.32 |
| Indicator | DPRO | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 61.21 | 36.40 |
| Support Level | $5.01 | $2.66 |
| Resistance Level | $6.51 | $3.46 |
| Average True Range (ATR) | 0.36 | 0.18 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 95.65 | 0.00 |
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The two segments are Drones, and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.